Increasing the Use of Medications for the Treatment of Alcohol Use Disorders (R01 Research Project Grant—Clinical Trial Optional)

Nov 10,2017 | Consortium staff Funding Opportunities

Posted by: NIH (PAR- 18-196)
Post date: November 1, 2017
Open date: January 6, 2018
Letter of Intent (LOI) due dates: 30 days prior to the application due date
Application due date: Standard due dates for R01 (Feb. 5; Jun. 5; Oct. 5)
Expiration date: May 8, 2020

This Funding Opportunity Announcement (FOA) encourages health services research designed to increase the public health impact of Food and Drug Administration (FDA)-approved pharmacotherapies for the treatment of alcohol use disorder. Significant progress is needed in developing generalizable, scalable, cost-effective strategies to move these evidence-based interventions into the mainstream of alcohol use disorder treatment, in both general medical and specialty care settings. The National Institute on Alcohol Abuse and Alcoholism (NIAAA) seeks applications to conduct hypothesis-driven research to identify effective methods for increasing the utilization of currently-available medications, by addressing their acceptability (to prescribers and patients), perceived effectiveness, affordability, and feasibility of use within existing care delivery systems.

Read PAR-18-196 for more information.